West Pharmaceutical Services Inc. Stock Slips 7.7%, Underperforms Peers
Dow Jones2026/07/24 20:33This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of West Pharmaceutical Services Inc. slipped 7.7% to $328.20 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index remaining mostly unchanged at 7,411.98 and the Dow Jones Industrial Average rising 0.5% to 51,947.25.
This was the stock's third consecutive day of losses.
West Pharmaceutical Services Inc. closed 15.0% short of its 52-week high of $386.00, which the company achieved on July 23rd.
The stock underperformed when compared to some of its peers, as Abbott Laboratories rose 2.3% to $103.06, Becton Dickinson & Co. rose 2.2% to $156.36, and Baxter International Inc. rose 3.37% to $22.40.
Trading volume totaled 1.5 million, compared to the 50-day average of 769,255.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
July 24, 2026 16:33 ET (20:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
ETF Craze Sweeps South Korean Market, Retail Investors' Net Purchase Nears 70 Trillion KRW
Carrier appoints PTC CEO Neil Barua to board
Dango Shutdown Marks Another Crypto Project Exit as DeFi Platform Winds Down Operations

Hyundai Motor Group unveils Physical AI vision at San Francisco AI Summit